Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, United Kingdom.
Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, United Kingdom.
Eur J Cell Biol. 2017 May;96(3):227-239. doi: 10.1016/j.ejcb.2017.03.005. Epub 2017 Mar 14.
Epithelial cells forming mammary gland ducts and alveoli require adhesion to the extracellular matrix for their function. Mammary epithelial cells need β1-integrins for normal cell cycle regulation. However, the role of β1-integrins in tumorigenesis has not been fully resolved. β1-integrin is necessary for tumour formation in transgenic mice expressing the Polyomavirus Middle T antigen, but it is dispensable in those overexpressing ErbB2. This suggests that some oncogenes can manage without β1-integrin to proliferate and form tumours, while others still require it. Here we have developed a model to test whether expression of an oncogene can surpass the need for β1-integrin to drive proliferation. We co-expressed the ErbB2 or Akt oncogenes with shRNA to target β1-integrin in mammary epithelial cells, and found that they show a differential dependence on β1-integrin for cell division. Moreover, we identified a key proliferative role of the Rac1-Pak axis downstream of β1-integrin signalling. Our data suggest that, in mammary epithelial cells, oncogenes with the ability to signal to Pak surpass the requirement of integrins for malignant transformation. This highlights the importance of using the correct combination therapy for breast cancer, depending on the oncogenes expressed in the tumour.
形成乳腺导管和腺泡的上皮细胞需要黏附在细胞外基质上才能发挥功能。乳腺上皮细胞需要β1 整合素来进行正常的细胞周期调控。然而,β1 整合素在肿瘤发生中的作用尚未完全解决。β1 整合素对于表达多瘤病毒中 T 抗原的转基因小鼠中的肿瘤形成是必需的,但对于过度表达 ErbB2 的小鼠则是可有可无的。这表明,一些致癌基因可以在没有β1 整合素的情况下增殖并形成肿瘤,而其他致癌基因仍然需要它。在这里,我们建立了一个模型来测试表达致癌基因是否可以超越对β1 整合素的需求来驱动增殖。我们在乳腺上皮细胞中共同表达 ErbB2 或 Akt 致癌基因和 shRNA 以靶向β1 整合素,发现它们对细胞分裂的β1 整合素依赖性存在差异。此外,我们确定了β1 整合素信号下游的 Rac1-Pak 轴在增殖中的关键作用。我们的数据表明,在乳腺上皮细胞中,具有信号传递到 Pak 能力的致癌基因超越了整合素对恶性转化的要求。这强调了根据肿瘤中表达的致癌基因,使用正确的联合疗法治疗乳腺癌的重要性。